Hepatitis B Virus Reactivation in Cancer Patients Undergoing Immune Checkpoint Inhibitors Therapy: A Systematic Review

Background: Immune checkpoint inhibitor (ICI) therapy is now administered to patients with advanced cancers. However, the safety and efficacy of ICIs in cancer patients with hepatitis B virus (HBV) infection is unknown. Therefore, we performed this systematic review to examine the safety and efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jian, Zhang, Yuehua, Qin, Siyuan, Zou, Bingwen, Wang, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723987/
https://www.ncbi.nlm.nih.gov/pubmed/36484006
http://dx.doi.org/10.7150/jca.77247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723987/
https://www.ncbi.nlm.nih.gov/pubmed/36484006
http://dx.doi.org/10.7150/jca.77247

Ejemplares similares